Skip to main content
Log in

Determinants of squamous intraepithelial lesions (SIL) on Pap smear: The role of HPV infection and of HIV-1-induced immunosuppression

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

This study aimed to identify risk factors for squamous intraepithelial lesions (SIL) in women with known HIV status and to explore the association between SIL, HPV subtype, and HIV-induced immunosuppression. The study population consisted of women with known HIV serological status who were attending a network of 16 clinical centres in Italy. Detailed behavioural data, clinical and laboratory parameters, and samples for diagnosis of SIL by Papanicolau smear and HPV infection using a polymerase chain reaction (PCR) were obtained from each study participant. The strength of the association between SIL and possible risk factors was assessed calculating crude and adjusted odds ratios derived from univariate analysis and multivariate models. We enrolled 236 women, of whom 135 (57.2%) were HIV-infected. SIL was diagnosed in 57 women (24.1%); of these, 48 (35.6%) were HIV-infected and 9 (8.9%) were HIV-negative. HPV-DNA was detected in 41 (72%) women with SIL and in 45 (25%) women without SIL. HPV-DNA was more often detected among HIV-infected women than among HIV-negative women (40% vs. 32%), but the difference was not statistically significant. Women infected with high-risk types or with low-risk-uncharacterised types of HPV both had a higher risk of SIL compared with HPV-negative women (respectively, AOR: 17.53 and AOR: 2.89). HIV-infected women with severe or moderate immunosuppression were more likely to have SIL than HIV-negative women (respectively, AOR: 7.29 and AOR: 3.09) also independently from HPV infection. Women reporting use of a contraceptive pill had a 2.5 times higher risk of SIL compared with those who never used hormonal contraceptives. The results confirm that high-risk HPV types are strongly associated with SIL, and that HIV infection may strengthen the effect of HPV at cervical level. The use of oral contraceptives may slightly increase the risk of SIL in women with at-risk behaviour for HIV infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85: 958–964.

    Google Scholar 

  2. Wright TC Jr, Ellerbrock TE, Chiasson MA, Van Devanter N, Sun XW, and The New York Cervical Disease Study. Cervical Intraepithelian Neoplasia in women infected with Human Immunodeficiency Virus: Prevalence, risk factors, and validity of Papanicolau smears. Obstet Gynecol 1994; 84: 591–597.

    Google Scholar 

  3. Maiman M, Fruchter RG, Guy L, Cuthill S, Levine P, Serur E. Human Immunodeficiency Virus Infection and Invasive Cervical Carcinoma. Cancer 1993; 71: 402–406.

    Google Scholar 

  4. Shafer A, Friedmann W, Mielke M, Schwartlander B, Koch MA. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol 1991; 164: 593–599.

    Google Scholar 

  5. Klein R.S. Ho GYF, Vermund SH, Fleming I, Burk RD. Risk factors for Squamous Intraepithelian Lesion on Pap smear in women at risk for Human Immunodefieciency Virus infection. J Inf Dis; 1994; 170: 404–409.

    Google Scholar 

  6. Laga M, Icenogle JI, Marsella R, Manoka AT, Nzila N, Ryder RW, Vermund SH, Heyward WIL, Nelson A, Reeves WC. Genital papillomavirus infection and cervical dysplasia-opportunistic complication of HIV infection. Int J Cancer 1992; 50: 45–48.

    Google Scholar 

  7. Schrager LK, Friedland GHD, Maude Schreiber K, Adachi A, Pizzuti DJ Koss LG, Klein RS. Cervical and vaginal squamous cell abnormalities in women infected with Human Immunodeficiency Virus. J of AIDS 1989; 2: 570–573.

    Google Scholar 

  8. Critchlow CW, Surawicz CM, Holmes KK, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995; 9: 1255–1262.

    Google Scholar 

  9. Morris JDH, Eddleston ALWF, Crook T. Viral infection and cancer. Lancet 1995; 346: 754–758.

    Google Scholar 

  10. National Cancer Institute Workshop. The 1988 Bethesda System for reporting cervico-vaginal cytological diagnoses. JAMA 1989; 262: 931–934.

    Google Scholar 

  11. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: Cytological and pathologic study of koilocytotic atypia. Ann NY Acad Sci 1956; 63: 1245–1261.

    Google Scholar 

  12. Higuchi R. Principles and application for DNA amplification. In: Erlich HA (ed), PCR technology. New York: M Stockton Press, 1989: 31–38.

    Google Scholar 

  13. Bernard G. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction (PCR) amplification restriction fragment length polymorphisms, nucleotide sequence, and phylogenetics algorithms. J Inf Disease 1994; 170: 1077–1085.

    Google Scholar 

  14. Herrington SC. Human papillomavirus and cervical neoplasia. Classification, virology, pathology and epidemiology. J Clin Patol 1994; 47: 1066–1072.

    Google Scholar 

  15. Harris RW, Brinton RA, Cowdell RH, et al. Characteristics of women with dysplasia or carcinoma in situ of the cervix. Br J Cancer 1980; 42: 359–369.

    Google Scholar 

  16. Franceschi S, Doll R, Gallwey J, La Vecchia C, Peto R, Spriggs AI. Genital warts and cervical neoplasia: An epidemiological study. Br J Cancer 1983: 48; 621–628.

    Google Scholar 

  17. Ho GYF, Burk RD, Fleming I, Klein RS. Risk of genital human papillomavirus in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer 1994; 53: 788–792.

    Google Scholar 

  18. Katz RL, Veanattukalathil S, Weiss KM. Human papillomavirus infection and neoplasia of the cervix and anogenital region in women with Hodgkins disease. Acta Cytol 1987; 31: 845–854.

    Google Scholar 

  19. Braun L. Role of human immunodeficiency virus infection in the pathogenesis of human papillomavirus-associated cervical neoplasia. Am J P 1994; 144: 209–214.

    Google Scholar 

  20. Halpert R, Fruchter RG, Sedis A, Butt K, Boyce JC, Sillman FH. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet Gynecol 1986; 68: 251–258.

    Google Scholar 

  21. Schneider V, Kay S, Lee HM. Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix. Acta Cytol 1983; 27: 220–224.

    Google Scholar 

  22. Vessey MP. Epidemiology of cervical cancer: Role of hormonal factors, cigarette smoking and occupation. In: Peto R, Zur Hausen H (eds), Viral etiology of cervical cancer. Banbury Report: Cold Spring Harbor Laboratory; 1986: 29–43.

  23. Serraino D, Napoli PA, Zaccarelli M, Alligro MB, Pezzotti P, Rezza G. High frequency of invasive cervical cancer among female injecting drug users with AIDS in Italy. AIDS 1996, 10: 1041–1042.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rezza, G., Giuliani, M., Branca, M. et al. Determinants of squamous intraepithelial lesions (SIL) on Pap smear: The role of HPV infection and of HIV-1-induced immunosuppression. Eur J Epidemiol 13, 937–943 (1997). https://doi.org/10.1023/A:1007466908865

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007466908865

Navigation